Talent.com
This job offer is not available in your country.
Executive Assistant to Professor Johann de Bono

Executive Assistant to Professor Johann de Bono

University PositionsSutton
30+ days ago
Salary
£35,150.00–£42,642.00 yearly
Job description

As Executive Assistant you will be required to provide highly efficient, proactive and comprehensive executive assistant support to aid the Head of Division in achieving their strategic and business objectives, successfully prioritising and balancing the varying demands of their specific workloads.

Key Requirements

The successful candidate for this challenging role will have excellent interpersonal skills and ideally a track record of providing personal assistant support at a senior executive level and / or exposure to cancer research. An ability to work flexibly under pressure, manage complex internal and external interactions, and interact effectively with the top executive and scientific teams will be essential for this role. The role includes complex diary management and assisting in the administrative management of laboratory, translational and clinical research, and will involve communicating with not only The ICR, The Royal Marsden and external research partner staff, but also cancer patients and their families. A high level of computer literacy is essential, together with the ability to learn and exploit new software packages as required in order to assist with manuscript, grant and clinical trial protocol preparation and submissions. The successful candidate will also have excellent secretarial skills, including accurate copy typing and experience of developing effective office systems, both manual and electronic.

Department / Directorate Information

The Drug Development Unit, within the ICR and Royal Marsden, is a dedicated Clinical Trials Unit, with bespoke facilities to conduct early phase clinical trials.

The Unit, led by Regius Professor Johann de Bono, comprises of clinicians, scientists, and study management staff, and focuses on providing a seamless conduit between pre-clinical drug discovery, proof of principle Phase-1 clinical trials and tumour specific evaluation of novel agents. The Unit undertakes both industry-sponsored and investigator-initiated trials of new anti-cancer drugs. The Unit is rapidly expanding and provides an excellent opportunity for the post holder to develop a variety of skillsets.